Rubius Therapeutics Inc (RUBY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -179,666 | -196,547 | -167,731 | -163,458 | -89,195 |
| Depreciation Amortization | 6,254 | 7,723 | 5,691 | 2,995 | 1,263 |
| Accounts payable and accrued liabilities | -9,811 | 5,858 | -1,369 | -1,037 | 4,938 |
| Other Working Capital | -17,525 | 6,694 | 112 | 10,444 | 119 |
| Other Operating Activity | 50,606 | 31,150 | 35,649 | 40,612 | 24,534 |
| Operating Cash Flow | $-150,142 | $-145,122 | $-127,648 | $-110,444 | $-58,341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -83,626 | N/A | -122,671 | -319,133 | -175,924 |
| PPE Investments | 12,639 | -3,649 | -5,497 | -40,657 | N/A |
| Sale Of Investment | 83,931 | 85,000 | 228,600 | 227,155 | 64,285 |
| Investing Cash Flow | $12,944 | $81,351 | $100,432 | $-132,635 | $-111,639 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 246 |
| Debt Issued | N/A | N/A | 25,000 | 25,000 | 25,000 |
| Debt Repayment | -75,702 | N/A | N/A | N/A | -5,500 |
| Common Stock Issued | 232 | 10,963 | 1,484 | 2,413 | 64 |
| Common Stock Repurchased | N/A | N/A | N/A | -122 | N/A |
| Other Financing Activity | 0 | 187,490 | 0 | 0 | 355,019 |
| Financing Cash Flow | $-75,470 | $198,453 | $26,484 | $27,291 | $374,829 |
| Beginning Cash Position | 227,583 | 92,901 | 93,633 | 309,421 | 104,572 |
| End Cash Position | 14,915 | 227,583 | 92,901 | 93,633 | 309,421 |
| Net Cash Flow | $-212,668 | $134,682 | $-732 | $-215,788 | $204,849 |
| Free Cash Flow | |||||
| Operating Cash Flow | -150,142 | -145,122 | -127,648 | -110,444 | -58,341 |
| Capital Expenditure | -5,304 | -3,649 | -5,497 | -40,657 | N/A |
| Free Cash Flow | -155,446 | -148,771 | -133,145 | -151,101 | -58,341 |